Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/37327959http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/37327959http://www.w3.org/2000/01/rdf-schema#comment"

Purpose

To describe the genetic and clinical spectrum of GUCY2D-associated retinopathies and to accurately establish their prevalence in a large cohort of patients.

Design

Retrospective case series.

Methods

Institutional study of 47 patients from 27 unrelated families with retinal dystrophies carrying disease-causing GUCY2D variants from the Fundación Jiménez Díaz hospital dataset of 8000 patients. Patients underwent ophthalmological examination and molecular testing by Sanger or exome sequencing approaches. Statistical and principal component analyses were performed to determine genotype-phenotype correlations.

Results

Four clinically different associated phenotypes were identified: 66.7% of families with cone/cone-rod dystrophy, 22.2% with Leber congenital amaurosis, 7.4% with early-onset retinitis pigmentosa, and 3.7% with congenital night blindness. Twenty-three disease-causing GUCY2D variants were identified, including 6 novel variants. Biallelic variants accounted for 28% of patients, whereas most carried dominant alleles associated with cone/cone-rod dystrophy. The disease onset had statistically significant differences according to the functional variant effect. Patients carrying GUCY2D variants were projected into 3 subgroups by allelic combination, disease onset, and presence of nystagmus or night blindness. In contrast to patients with the most severe phenotype of Leber congenital amaurosis, 7 patients with biallelic GUCY2D had a later and milder rod form with night blindness in infancy as the first symptom.

Conclusions

This study represents the largest GUCY2D cohort in which 4 distinctly different phenotypes were identified, including rare intermediate presentations of rod-dominated retinopathies. We established that GUCY2D is linked to about 1% of approximately 3000 molecularly characterized families of our cohort. All of these findings are critical for defining cohorts for inclusion in future clinical trials."xsd:string
http://purl.uniprot.org/citations/37327959http://purl.org/dc/terms/identifier"doi:10.1016/j.ajo.2023.05.015"xsd:string
http://purl.uniprot.org/citations/37327959http://purl.uniprot.org/core/author"Romero R."xsd:string
http://purl.uniprot.org/citations/37327959http://purl.uniprot.org/core/author"Avila-Fernandez A."xsd:string
http://purl.uniprot.org/citations/37327959http://purl.uniprot.org/core/author"Ayuso C."xsd:string
http://purl.uniprot.org/citations/37327959http://purl.uniprot.org/core/author"Riveiro-Alvarez R."xsd:string
http://purl.uniprot.org/citations/37327959http://purl.uniprot.org/core/author"Trujillo-Tiebas M.J."xsd:string
http://purl.uniprot.org/citations/37327959http://purl.uniprot.org/core/author"Blanco-Kelly F."xsd:string
http://purl.uniprot.org/citations/37327959http://purl.uniprot.org/core/author"Corton M."xsd:string
http://purl.uniprot.org/citations/37327959http://purl.uniprot.org/core/author"Garcia-Sandoval B."xsd:string
http://purl.uniprot.org/citations/37327959http://purl.uniprot.org/core/author"Lopez M.A."xsd:string
http://purl.uniprot.org/citations/37327959http://purl.uniprot.org/core/author"Zurita O."xsd:string
http://purl.uniprot.org/citations/37327959http://purl.uniprot.org/core/author"Villaverde C."xsd:string
http://purl.uniprot.org/citations/37327959http://purl.uniprot.org/core/author"Martin-Gutierrez M.P."xsd:string
http://purl.uniprot.org/citations/37327959http://purl.uniprot.org/core/author"Carreno E."xsd:string
http://purl.uniprot.org/citations/37327959http://purl.uniprot.org/core/author"Jimenez-Rolando B."xsd:string
http://purl.uniprot.org/citations/37327959http://purl.uniprot.org/core/author"Martin-Merida I."xsd:string
http://purl.uniprot.org/citations/37327959http://purl.uniprot.org/core/author"Del Pozo-Valero M."xsd:string
http://purl.uniprot.org/citations/37327959http://purl.uniprot.org/core/author"Minguez P."xsd:string
http://purl.uniprot.org/citations/37327959http://purl.uniprot.org/core/author"Iancu I.F."xsd:string
http://purl.uniprot.org/citations/37327959http://purl.uniprot.org/core/author"Perea-Romero I."xsd:string
http://purl.uniprot.org/citations/37327959http://purl.uniprot.org/core/author"Swafiri S.T."xsd:string
http://purl.uniprot.org/citations/37327959http://purl.uniprot.org/core/author"Nunez-Moreno G."xsd:string
http://purl.uniprot.org/citations/37327959http://purl.uniprot.org/core/author"Rodilla C."xsd:string
▶